Amgen (AMGN) Intangibles (2009 - 2026)
Amgen (AMGN) posted quarterly Intangibles of $21.4 billion for Q1 2026, up 345.4% year-over-year from $4.8 billion in Q1 2025, and down 4.03% quarter-over-quarter from $22.3 billion in Q4 2025.
Amgen (AMGN) Intangibles (2009 - 2026) Analysis & Trends
Amgen's Intangibles history runs 18 years deep, the most recent figure standing at $21.4 billion for Q1 2026.
- In Q1 2026, Intangibles rose 345.4% year-over-year to $21.4 billion; the TTM figure through Mar 2026 stood at $21.4 billion (up 345.4% YoY), while the FY2025 annual figure was $22.3 billion, down 19.58% from the prior year.
- Intangibles for Q1 2026 stood at $21.4 billion, down from $22.3 billion in the prior quarter.
- The five-year high for Intangibles was $32.6 billion in Q4 2023, with the low at $350.0 million in Q2 2025.
- The 5-year median for Intangibles is $16.1 billion (2022), against an average of $19.0 billion.
- The sharpest annual moves came in 2025 and 2026: Intangibles plunged 98.84% in 2025, then surged 345.4% in 2026.
- Amgen's Intangibles stood at $16.1 billion in 2022, then jumped by 102.99% to $32.6 billion in 2023, then dropped by 15.14% to $27.7 billion in 2024, then slipped by 19.58% to $22.3 billion in 2025, then fell by 4.03% to $21.4 billion in 2026.
- Business Quant data shows AMGN's Intangibles at $21.4 billion in Q1 2026, $22.3 billion in Q4 2025, and $23.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 22.54 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 30.64 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.49 Bn |
| Mar 31, 2026 | 21.38 Bn |
| Dec 31, 2025 | 22.28 Bn |
| Sep 30, 2025 | 23.14 Bn |
| Jun 30, 2025 | 350.00 Mn |
| Mar 31, 2025 | 4.80 Bn |
| Dec 31, 2024 | 27.70 Bn |
| Sep 30, 2024 | 28.92 Bn |
| Jun 30, 2024 | 30.17 Bn |
| Mar 31, 2024 | 31.37 Bn |
| Dec 31, 2023 | 32.64 Bn |
| Sep 30, 2023 | 13.15 Bn |
| Jun 30, 2023 | 14.63 Bn |
| Mar 31, 2023 | 15.39 Bn |
| Dec 31, 2022 | 16.08 Bn |
| Sep 30, 2022 | 13.27 Bn |
| Jun 30, 2022 | 13.93 Bn |
| Mar 31, 2022 | 14.57 Bn |
| Dec 31, 2021 | 15.18 Bn |
| Sep 30, 2021 | 14.66 Bn |